|
Volumn 33, Issue 5, 1998, Pages 556-588
|
Quetiapine and ropinirole
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACTIVATED CARBON;
ALCOHOL;
AMANTADINE;
ANTIHYPERTENSIVE AGENT;
BROMOCRIPTINE;
CABERGOLINE;
CARBIDOPA PLUS LEVODOPA;
CHLORPROMAZINE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CLOZAPINE;
DOPAMINE RECEPTOR STIMULATING AGENT;
IBUPROFEN;
LEVODOPA;
MEXILETINE;
NEUROLEPTIC AGENT;
OLANZAPINE;
PERGOLIDE;
PLACEBO;
PRAMIPEXOLE;
PROBENECID;
QUETIAPINE;
QUINIDINE;
QUININE;
RISPERIDONE;
ROPINIROLE;
SELEGILINE;
TRIAMTERENE;
UNINDEXED DRUG;
VERAPAMIL;
ASTHENIA;
BLOOD TOXICITY;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG INDICATION;
EDEMA;
GASTROINTESTINAL TOXICITY;
HUMAN;
NEUROTOXICITY;
PARKINSON DISEASE;
PSYCHOSIS;
REVIEW;
SCHIZOPHRENIA;
SOMNOLENCE;
URINARY TRACT INFECTION;
VERTIGO;
VISUAL IMPAIRMENT;
|
EID: 0031970841
PISSN: 00185787
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (0)
|